Cancer patients at the Sylvester Comprehensive Cancer Center that participated in a clinical trial for ovarian cancer have impacted the way the disease is understood. The study proved that an anti-cancer drug called veliparib, which targets the way DNA repairs itself, might help up to 30% more patients. Yourway increases access to life-saving medicine by being on the forefront of the clinical trial supply chain.